Data / Form D filings / Intus Biosciences, LLC
Intus Biosciences, LLC: Form D filings
Intus Biosciences, LLC, a biotechnology company in Farmington, CT, filed 11 Form D notices with the SEC between 2016 and 2025. The latest, on May 27, 2025, reports $1.1 million sold of a $3 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 FARMINGTON AVENUE, Farmington, CT, 06032
- Phone
- (203) 619-4083
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Connecticut
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1664615
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2025 | New notice | $3,000,000 | $1,089,996 | $1,910,004 | 8 | May 15, 2025 | sec.gov |
| Jul 16, 2024 | New notice | $2,000,000 | $2,000,000 | 25 | Jun 25, 2024 | sec.gov | |
| Nov 16, 2022 | New notice | $3,490,477 | $1,050,003 | $2,440,474 | 1 | Nov 7, 2022 | sec.gov |
| Jul 7, 2022 | New notice | $1,500,000 | $800,000 | $700,000 | 1 | Jun 27, 2022 | sec.gov |
| Feb 3, 2022 | New notice | $250,000 | $250,000 | 4 | Jan 22, 2022 | sec.gov | |
| Jan 8, 2021 | New notice | $1,000,000 | $330,000 | $670,000 | 5 | Dec 23, 2020 | sec.gov |
| May 27, 2020 | Amendment | $2,214,434 | $2,214,434 | 16 | May 23, 2019 | sec.gov | |
| Aug 12, 2019 | New notice | $1,714,579 | $884,578 | $830,001 | 16 | May 23, 2019 | sec.gov |
| Dec 28, 2017 | New notice | $1,917,059 | $1,842,059 | $75,000 | 10 | Dec 15, 2017 | sec.gov |
| May 31, 2016 | New notice | $500,000 | $500,000 | 1 | May 13, 2016 | sec.gov | |
| Jan 25, 2016 | New notice | $500,000 | $40,000 | $460,000 | 1 | Jan 7, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donna J. Galluzzo | Director | |
| Paul Denslow | Executive Officer, Director | |
| Frank J. Marco | Director | |
| Alan J. Mendelson | Director | |
| Daniel J. Wagner | Director | |
| Mark J. Driscoll | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of May 26, 2025 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Intus Biosciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.